Pharmaceutical Development

Erwinase® gains Marketing Approval in Japan

Porton Biopharma Limited has been working to support Ohara Pharmaceutical Co. Ltd. who have announced that they have obtained marketing approval for Erwinase® from the Ministry of Health Labour and Welfare in Japan.

The full Ohara press release can be viewed on their website at http://www.ohara-ch.co.jp/english/

Porton Biopharma is the sole manufacturer of Erwinase® and this announcement marks a milestone by increasing the number of territories in which the product is approved.